4.8 Editorial Material

Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 130, Issue 7, Pages 3345-3347

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI139642

Keywords

COVID-19

Funding

  1. National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH [T32AR048522]
  2. National Science Foundation Graduate Research Fellowship [DGE-1656518]
  3. Microsoft Research
  4. Burroughs Wellcome Career Award for Medical Scientists
  5. National Cancer Institute [R37CA230400, K08CA230179, U01CA247576]
  6. National Institute of Neurological Disorders and Stroke grant [R21NS113016]
  7. Department of Defense [W81XWH-16-0078, W81XWH1810236]
  8. Sontag Foundation Distinguished Scientist Award
  9. Virginia and D.K. Ludwig Fund for Cancer Research
  10. Lustgarten Foundation for Pancreatic Cancer Research
  11. BKI Cancer Genetics and Genomics Research Program
  12. U.S. Department of Defense (DOD) [W81XWH1810236] Funding Source: U.S. Department of Defense (DOD)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available